Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Nifedipine

supplement:

Adenosine

Research Papers that Mention the Interaction

Interaction between nifedipine and adenosine should be kept in mind when treating patients with nifedipine.
It is probable that nifedipine exerts part of its physiological actions through potentiation of adenosine.
General pharmacology  •  1986  |  View Paper
Adenosine , in concentrations achieved in the plasma during myocardial ischemia (0.01-0.1 microM), enhanced the inhibitory effects of nifedipine , verapamil and diltiazem on platelet aggregation 5-100 fold.
In the presence of non-inhibitory concentrations of adenosine, nifedipine , in concentrations approaching those attained in vivo following standard therapeutic doses (as low as 0.29 microM), significantly inhibited thromboxane A2-induced platelet aggregation.
Thrombosis research  •  1990  |  View Paper
This interaction might be due to the inhibitory effects of nifedipine and Bay K 8644 on the uptake of adenosine by rat brain.
Pharmacological research  •  1996  |  View Paper
Concurrent administration of verapamil with adenosine neither affected the hyperglycaemic nor the hypoinsulinaemic effects of adenosine, whereas combined administration of nifedipine and adenosine decreased the hyperglycaemic effect of adenosine but not its hypoinsulinaemic effect.
Arzneimittel-Forschung  •  1995  |  View Paper
2 Nifedipine and Bay K 8644, a calcium channel antagonist and activator respectively, enhanced the inhibitory action of adenosine in a concentration‐dependent manner.
4 Addition of the adenosine uptake blocker dipyridamole reversed the action of nifedipine on adenosine, so that inhibition by adenosine was now attenuated by nifedipine in a similar manner to that observed with the adenosine analogues.
British journal of pharmacology  •  1990  |  View Paper
Several analogues of adenosine which are not substrates for the uptake system also depressed the population spikes in the CA1 region but these responses were inhibited by nifedipine and BAYK 8644.
Brain Research  •  1990  |  View Paper
Previous pharmacologic studies indicating competitive interactions between adenosine and nifedipine at the adenosine vascular receptor suggest that adenosine may he a less effective hypotensive drug after pretreatment with nifedipine.
The present findings may have clinical relevance in patients with cardiovascular disease being treated with nifedipine who may need adenosine to lower blood pressure either to decrease bleeding or to decrease myocardial work and oxygen consumption.
Anesthesia and analgesia  •  1989  |  View Paper
In contrast to receptor-binding studies requiring high ratios of the drugs to adenosine receptor radioligands, nifedipine and nisoldipine were inhibitory at equimolar concentrations with adenosine.
Biochemical pharmacology  •  1986  |  View Paper
Nifedipine decreased the release of adenosine , inosine and (hypo)-xanthine during ischemia and reperfusion.
Advances in experimental medicine and biology  •  1984  |  View Paper
Furthermore, the negative interaction of nifedipine and adenosine in vivo suggests that these agents might act differently in an in vitro setting.
The calcium channel blocker nifedipine attenuates the coronary response to adenosine infusion and reactive hyperemia in dogs.
Canadian journal of physiology and pharmacology  •  1983  |  View Paper
Show More